Navigation Links
Barr in Medical News

Teva and Barr Receive FTC Request for Additional Information

JERUSALEM and MONTVALE, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) and Barr Pharmaceuticals, Inc. (NYSE: BRL ) announced today that, as expected, each party has received a request for additional information (commonly referred to as a "second r...

Wendel Barr Appointed Chief Operating Officer of Covance

- Mike Lehmann Named President, Labs North America - PRINCETON, N.J., Dec. 18 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that Wendel Barr has been named Covance's Chief Operating Officer, effective January 1, 2008. Mr. Barr, who is currently President of Early...

Watson Confirms Patent Litigation With Barr Related to Seasonale(R)

CORONA, Calif., Dec. 14 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, confirmed today that Duramed Pharmaceuticals, Inc., a wholly owned subsidiary of Barr Pharmaceuticals, Inc., has filed a patent lawsuit against Watson and c...

Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr

CORONA, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being divested as a result of the proposed merger bet...

Epstein - Barr virus Protein Implicated in Blood Cancer

Researchers at the University Of Pennsylvania School Of Medicine had identified a link between an Epstein - Barr virus (EBV) protein and a vital cancer pathway earlier this year//. They have now proceeded further in this research and have found that the viral protein, named EBNA3C is responsible fo...

Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ

...rstCall/ -- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that its partner Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) (previously barr Laboratories Inc.) has received final approval from the U.S. Food and Drug Administration to market Triamcinolone Acetonide Nasal Spray containing a p...

Mylan Announces Enhancements to Executive Management Team

...president, Global Generic Sales and Marketing, for barr Laboratories, whose parent company, barr Pharmaceuticals, was acquired by Teva. In that pos...s vice president, Generic Sales and Marketing, for barr Laboratories. In that role, he led the company's e...

Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook

...ther revenue decreased $25.0 million to $7.4 million. Generic other revenue for the second quarter 2008 included a $15.0 million sales milestone from barr Pharmaceuticals, Inc. following a 1999 legal settlement. Adjusted Generic gross profit was $175.2 million in the second quarter of 2009, compar...

Cardinal Health Appoints Bruce Downey to Board of Directors; John McCoy Retires From Board After 22 Years

...board for personal reasons after 22 years of service to the company as a director. Downey is the former chairman and chief executive officer of barr Pharmaceuticals, Inc. and past chairman of the Generic Pharmaceutical Association. "John McCoy has been a committed board member for more than t...

Boost Natural Killer Cells to Prevent Swine Flu

...drome, fibromyalgia, Lymes Disease, Babesia, or HIV are more likely to have lower Natural Killer Cell levels. Herpes Simplex, Human Herpes 6, Epstein barr and Cytomegalus viruses also suppress immunity. Dr. Sponaugle also recommends reducing sugar consumption, to increase immunity. Studies reveal c...

BioTech Firm Decodes Current Swine Flu BioMarkers

...ful results that enhance and support the body's innate ability to protect itself efficiently from pathogens and viruses such as Herpes and the Epstein barr Virus. The process of Sound Presentation consists of monitoring biofeedback responses while playing specially selected combinations of low frequency ...

Private-label OTC Drugs Post Solid Gains in 2008, According to Kline

...s was the other area that grew 7.3% in 2008 as a result of strong sales growth of personal lubricants, as well as the Rx-to-OTC switch brand Plan B by barr Laboratories. "By contrasting the overall growth rates for OTCs with the growth rates for private-label products we can easily make the case tha...

Preventing Shaken Baby Syndrome

...blic health work because the results show it's possible to change people's ideas about crying," said Dr. Ronald Barr, the lead author of both studies. barr is director of community child health at the Child & Family Research Institute and a professor of pediatrics at the University of British Columbia...

Educational materials increase knowledge and behaviors important for preventing shaken baby syndrome

... Ronald Barr, the lead author of both studies. Dr. barr is head of community child health at the Child & F...edicine at the University of British Columbia. Dr. barr is a Canada Research Chair in Community Child Heal...ers about the dangers of shaking an infant. Dr. barr and Ms. Marilyn Barr, Executive Director of the Na...

Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008

...uarter, a decrease of $2.7 million. Recent Highlights In December 2008, the Company entered into a settlement and license agreement with barr Pharmaceuticals, Inc., which was subsequently acquired by Teva Pharmaceutical Industries, Ltd., to resolve the pending patent litigation relating to F...

Sanofi-aventis Delivers 2008 Results Above Guidance

...XRP6258 in breast cancer (EUR 1,175 million) and the settlement agreed with barr relating to Nasacort(R) in November 2008. This adjustment has no cash impac...nd XRP6258 in breast cancer (EUR 1,175 million), the settlement agreed with barr relating to Nasacort(R) in November 2008, and the discontinuation of ilepat...

Perrigo Reports Record Second Quarter Sales

...atent litigation brought by Sanofi-Aventis against barr Laboratories, Inc. (Barr), a subsidiary of barr Pharmaceuticals, Inc. The suit was brought in the ...ng a paragraph IV certification for NASACORT(R)AQ. barr developed its Triamcinolone Acetonide Nasal Spray ...

Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation

... market. The agreement covering Femcon(R) Fe will permit Watson to commence marketing its generic equivalent product on the earlier of 180 days after barr Laboratories, Inc. (now Teva Pharmaceutical Industries, Ltd.) enters the market with a generic equivalent product, or January 1, 2013. The parties wi...

Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA

... MONTVALE, N.J., Dec. 11 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announc.... Barr/DOD Project Summary In 2001, barr entered into a multi-year agreement with the U.S. ... Vaccines, Type 4 and 7. As part of the agreement, barr constructed a dedicated facility to support the pr...

FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream

... MONTVALE, N.J., Dec. 1 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announc...d risks for the individual woman. About barr Pharmaceuticals, Inc. barr Pharmaceuticals, Inc. is a global specialty pharma...

Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg

... MONTVALE, N.J., Nov. 26 /PRNewswire/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed that its subsidiary, barr Laboratories, Inc., has initiated a challenge of t...extended-release capsules, 15mg and 30mg. barr filed its Abbreviated New Drug Application (ANDA) ...

Barr Shareholders Approve Pending Teva Acquisition

... MONTVALE, N.J., Nov. 21 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announc...s submitted to them relating to the acquisition of barr by Teva Pharmaceuticals Industries Ltd. (Nasdaq: ...the overwhelming support of the transaction by the barr shareholders," said Bruce L. Downey, Barr's Chairm...

Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation

...n brought by Sanofi-Aventis (NYSE: SNY ) against barr Laboratories, Inc. a subsidiary of barr Pharmaceuticals, Inc. (NYSE: BRL ). The suit wa...al Spray containing a paragraph IV certification. barr believes that it is the first to file an Abbreviat...

Barr Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent Challenges

...MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announced that its subsidiary, barr Laboratories, Inc. has entered into separate settl...bout the possible impact of ongoing litigation for barr and Teva related to the launch of generic versions...

Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL

... MONTVALE, N.J., Nov. 3 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announce...nded August 2008, based on IMS sales data. About barr Pharmaceuticals, Inc. barr Pharmaceuticals, Inc. is a global specialty pharma...

World Anticoagulants Market to Exceed $12 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

...h US$38.3 million. In Europe, France represents the largest market with a 23.8% share. Major market participants profiled include AstraZeneca PLC, barr Laboratories Inc., Bristol-Myers Squibb Company, Celgene Corporation, GlaxoSmithKline plc, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., and Sano...

Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges

... MONTVALE, N.J., Aug. 12 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) announced today that its barr Laboratories subsidiary has signed a Settlement Ag...ringer Ingelheim's Mirapex(R) product. Separately, barr Laboratories entered into a Settlement Agreement a...

Barr Confirms Patent Challenge of Xyzal(R), 5mg Tablets

... MONTVALE, N.J., July 31 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed that its subsidiaries, barr Laboratories, Inc. and PLIVA-Hrvatska D.O.O., have...r the twelve month period ending May 2008. About barr Pharmaceuticals, Inc. ...

Grant will help patients with schizophrenia who smoke

... Dr Ruth Barr, a psychiatrist in the School of Medicine and Dentistry. Dr barr hopes to build on research she has carried out during a fellowship at Harva...nd 40 volunteers, including both those with and without the condition. Dr barr said: "The reasons behind the increased need to smoke in patients with schi...

Barr Will Host an Earnings Conference Call on August 7, 2008 to Discuss the Results for the Second Quarter of Calendar 2008

... MONTVALE, N.J., July 3 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announce...d or install any necessary audio software. About barr Pharmaceuticals, Inc. barr Pharmaceuticals, Inc. is a global specialty pharma...

Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives

... - barr Plans to Launch Generic Yasmin(R) on or before July 1, 2008 - barr Plans to Launch Generic Yaz(R) on or before July 1... MONTVALE, N.J., June 24 /PRNewswire-FirstCall/ -- barr Pharmaceuticals, Inc. (NYSE: BRL ) today announce...

AGA Medical Announces Management Transition

...nt of North American Operations and a member of the Board of Directors for Haemonetics Corporation and in a variety of roles at Baxter Healthcare. Mr. barr has a B.S. in Bioengineering from the University of Pennsylvania and an MBA from the Kellogg School of Management at Northwestern University. ABOUT ...

Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation

...ents UPS Verizon Communications Xerox Corporation Prescription Drug Stakeholders Pharmaceutical Care Management Association (PCMA) Aetna barr Pharmaceuticals, Inc. BlueCross BlueShield Association CIGNA CVS Caremark Coalition for a Competitive Pharmaceutical Market Express Scripts,...

Stronger-Than-Ever Generic Threat Forces Big Pharma to Be Creative

... are seeing the benefit of incorporating a generic unit." Generic drug makers are also becoming more aggressive, challenging brand patents. TEVA and barr have been instrumental in pushing to introduce generic versions of brand name drugs long before U.S. patents expire. Kalorama Information's report W...

Leading experts investigate Shaken Baby Syndrome

... lives. Guest Editors Robert M. Reece, Desmond K. Runyan, and Ronald G. barr and an international group of authors significantly contribute to the incre...erived from prospective active surveillance studies, and Runyan, Berger and barr provide an integrative proposal for the ideal system to measure inflicted n...

Barr Will Host An Earnings Conference Call on May 8, 2008 to Discuss the Results for the First Quarter of Calendar 2008

...d or install any necessary audio software. About barr Pharmaceuticals, Inc. barr Pharmaceuticals, Inc. is a global specialty pharma...ive pharmaceutical ingredients. A holding company, barr operates through its principal subsidiaries: Barr ...

Barr Announces Reorganization of Senior Management, Business Functions

...ur, Esq. has been named Chief Executive Officer of barr Laboratories, Inc., the Company's generic pharmace... been named President and Chief Operating Officer, barr Laboratories, Inc., reporting to Mundkur; and, Tim...ice President, Global Generic Sales and Marketing, barr Laboratories, Inc. reporting to Mundkur. In additi...

Barr Pharmaceuticals, Inc. Executive Bios

... Chief Executive Officer, barr Laboratories, Inc. -- In this newly created posi...nd sales and marketing. Under her leadership, barr Laboratories will continue to support the prop... Operations. -- Barr: 15 years * Joined barr In 1993 As An Associate Counsel. * Named Dir...

Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange

...rman and CEO. In addition, Downey confirmed that barr does not anticipate initiating a squeeze-out of re...pleting the integration of PLIVA's operations into barr and focusing on business growth in key world markets." On October 24, 2006, barr finalized the legal and regulatory requirements to...

UNC, Duke lead first statewide shaken baby prevention research project in US

... National Center on Shaken Baby Syndrome. Both Dr. barr and Marilyn barr are collaborating with the North Carolina project. Dr. barr created the concept of The Period of PURPLE Crying...
Other Tags
(Date:7/9/2014)... Tampa, Fla. (July 9, 2014) Emerging fungal ... any other parasitic group, causing population declines of ... from the University of South Florida published in ... amphibians can acquire behavioral or immunological resistance to ... population declines. , "Acquired resistance is important ...
(Date:7/9/2014)... Researchers from The Cancer Genome Atlas (TCGA) Research ... cancer-causing pathway in lung adenocarcinoma, the most common ... changes may expand the number of possible therapeutic ... greater number of patients with treatable mutations because ... already exist. , TCGA is jointly funded and ...
(Date:7/9/2014)... new study shows that some shark species may be able ... may come with rising temperatures. , The Arctic today is ... it wasn,t always like that. Roughly 53 to 38 million ... the Arctic was more similar to a huge temperate forest ... including ancestors of tapirs, hippo-like creatures, crocodiles and giant tortoises. ...
Breaking Biology News(10 mins):USF study: Amphibians can acquire resistance to deadly fungus 2Study identifies novel genomic changes in the most common type of lung cancer 2Study identifies novel genomic changes in the most common type of lung cancer 3Shark teeth analysis provides detailed new look at Arctic climate change 2Shark teeth analysis provides detailed new look at Arctic climate change 3
(Date:7/9/2014)... Cup highlights, Brian Williams refreshing old school rap classics, ... railings. A University of Colorado Cancer Center study published ... YouTube also allows researchers, journals, and health advocates to ... cancer and prevention. , "No matter what field you,re ... communicate around the world," says Chante Karimkhani, MD candidate ...
(Date:7/9/2014)... Infectious Diseases (NIAID), part of the National Institutes ... of CRS3123, an investigational oral antibiotic intended to ... ) infection. CRS3123 (previously known as REP3123) is ... while sparing normal intestinal bacteria. , The Phase ... men and women ages 18 to 45 in ...
(Date:7/9/2014)... (July 9, 2014) A retrospective study conducted by ... colleagues reports that among adults with intellectual and developmental ... number of years receiving dental care increased. The findings, ... in Dentistry , may help improve interventions designed to ... , The researchers reviewed the dental records of ...
(Date:7/9/2014)... age with kidney and heart disease have raised concerns ... adults. However, in the first study to look closely ... Medicine at the University of Pennsylvania report that older ... expectancy and cardiovascular health as very healthy older people ... the ever increasing organ transplant waitlists, the authors of ...
(Date:7/9/2014)... published in the scientific journal Nature Neuroscience ... at Universit Laval, reveals that it is possible to ... rekindling pain so that it can subsequently be erased. ... chronic pain. , The researchers from the Faculty of ... mentale de Qubec (IUSMQ) were inspired by previous work ...
Breaking Medicine News(10 mins):Health News:Study of dermatology on YouTube shows new ways science reaches public 2Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3Health News:Penn study finds living kidney donation does not increase risk of death or heart disease for older 2Health News:Discovery of a new means to erase pain 2
Other Contents